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Introduction
The restoration of  functional tissue architecture after injury is critical to ensure the survival of  an organism. 
If  an injury persists or is of  great enough magnitude, then physiological wound repair becomes patholog-
ical, leading to a fibrotic response, a reduction in tissue function, organ failure, and ultimately death (1, 
2). Fibrosis is defined by an excessive and dysregulated accumulation of  collagen and extracellular matrix 
(ECM) and can affect any tissue/organ (3).
The effective modulation of  the magnitude, duration, and resolution of  the inflammatory response is 
critical to determining the physiological versus pathological response to tissue injury. In response to tissue 
injury, damage-associated molecular patterns (DAMPs) are released from stressed and dead/dying cells 
and are critical to the initiation of  an inflammatory response. DAMPs encompass a group of  heteroge-
neous molecules that initiate and amplify innate immune signalling pathways by engaging pattern recogni-
tion receptors (PRRs) to promote inflammatory pathways (4). N-formyl peptide (fMLF) receptors (FPRs) 
are a family of  PRRs that elicit important regulatory effects in multiple pathological conditions, including 
inflammation and cancer (5–7). In humans, 3 variants of  FPR have been identified (FPR-1 to -3), yet it is 
FPR-1 that has been most intently studied (5). The principal ligands for FPR-1 are bacterial formylated 
peptides that are actively secreted by invading pathogens or mitochondrial formylated peptides that are 
passively released from dead and dying host cells after tissue injury (8, 9). However, an increasing number 
of  alternative, non–formyl peptide ligands for FPR-1 are being uncovered, including cathepsin G (10), 
annexin-1 (11), and FAM19A4 (12), highlighting the promiscuous nature of  FPR-1.
Neutrophils are the most abundant inflammatory cells at the earliest stages of wound healing and 
play important roles in wound repair and fibrosis. Formyl peptide receptor 1 (FPR-1) is abundantly 
expressed on neutrophils and has been shown to regulate their function, yet the importance of 
FPR-1 in fibrosis remains ill defined. FPR-1–deficient (fpr1–/–) mice were protected from bleomycin-
induced pulmonary fibrosis but developed renal and hepatic fibrosis normally. Mechanistically, 
we observed a failure to effectively recruit neutrophils to the lungs of fpr1–/– mice, whereas 
neutrophil recruitment was unaffected in the liver and kidney. Using an adoptive transfer model 
we demonstrated that the defect in neutrophil recruitment to the lung was intrinsic to the fpr1–/– 
neutrophils, as C57BL/6 neutrophils were recruited normally to the damaged lung in fpr1–/– mice. 
Finally, C57BL/6 mice in which neutrophils had been depleted were protected from pulmonary 
fibrosis. In conclusion, FPR-1 and FPR-1 ligands are required for effective neutrophil recruitment 
to the damaged lung. Failure to recruit neutrophils or depletion of neutrophils protects from 
pulmonary fibrosis.
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FPR-1 was originally described on human neutrophils, where its activation was shown to trigger a wide 
variety of  functions, including chemotaxis, degranulation, ROS production, and phagocytosis (13, 14). More 
recent data have shown FPR-1 to be expressed on human monocytes and macrophages (15), bronchial and 
colonic epithelial cells (16, 17), and fibroblasts/myofibroblasts from several tissues (18, 19). FPR-1 expression 
was shown to be increased in skin fibroblasts isolated from patients with systemic sclerosis compared with 
normal subjects and to play an important role in regulating fibroblast to myofibroblast transition in vitro (18). 
However, the importance of  FPR-1 in the initiation and progression of  fibrosis is ill investigated and further in 
vivo work is required to tease out the potential therapeutic benefit of  targeting the receptor.
Here, we investigated the role of  FPR-1 in the initiation and potentiation of  fibrosis in multiple organs 
(lung, liver, and kidney) by examining differences in fibrogenic responses between C57BL/6 WT and fpr1–/– 
mice. Although FPR-1 was found to be dispensable for induced fibrosis in the liver and kidney, absence of  
FPR-1 protected the lung from bleomycin-induced inflammation and subsequently fibrosis. Moreover, we 
demonstrate that FPR-1 is crucial for neutrophil recruitment to the lung, whereas, by contrast, neutrophils 
are recruited to the liver and kidney via FPR-1–independent mechanisms. Experimental depletion of  neu-
trophils afforded a protective antifibrogenic effect in bleomycin-injured animals. Hence, we have discovered 
that FPR-1+ neutrophils play a distinct organ-specific role in fibrosis, being essential for pathological tissue 
remodeling in the diseased lung.
Results
Mice deficient in FPR-1 are protected from bleomycin-induced lung inflammation and fibrosis. WT C57BL/6 and 
fpr1–/– mice were challenged intratracheally with saline (control) or bleomycin sulfate (0.007 U) and har-
vested on days 1, 5, and 21 to assess inflammation and fibrosis (Figure 1A). Fibrosis, as quantified by 
hydroxyproline content of  lung tissue, increased approximately 2-fold (compared with saline) in response 
to bleomycin challenge in C57BL/6 mice on day 21. Critically, total lung collagen content was significantly 
lower in bleomycin-challenged fpr1–/– mice compared with C57BL/6 mice on day 21 (2.89 ± 0.28 vs. 4.11 
± 0.36 μg/lobe; P = 0.007) (Figure 1B). Histologically, the extensive tissue remodeling that is classically 
observed in response to bleomycin challenge was seen in C57BL/6 mice (Figure 1C) and was accompa-
nied by an increase in the percentage area positive for Picrosirius red (collagen type I–III) (Figure 1D) and 
α-smooth muscle actin (αSMA) (activated myofibroblasts) (Figure 1E). Conversely, fpr1–/– mice displayed 
little to no evidence of  tissue remodeling and had significantly attenuated collagen type I–III deposition 
(7.86 ± 0.74 vs. 14.76 ± 2.45%; P = 0.014) and myofibroblast activation (3.65 ± 0.22 vs. 6.56 ± 0.86%; P 
= 0.014) compared with C57BL/6 mice. Moreover, fpr1–/– mice were attenuated for bleomycin-induced 
expression of  genes encoding ECM proteins (collagen type I, fibronectin, elastin) and tissue remodeling 
enzymes (MMP-2) (all P < 0.05) (Figure 1, F–I).
To assess inflammation in C57BL/6 and fpr1–/– mice, lung tissue homogenates were prepared on days 5 
and 21 after challenge and expression of  KC, MCP-1, IL-1β, and IL-6 quantified. In bleomycin-challenged 
C57BL/6 mice, we observed significant increases in KC, MCP-1, and IL-6 expression on day 5 compared 
with saline-challenged control mice. On day 21, there was a subsequent reduction back to baseline expres-
sion levels for KC, MCP-1, and IL-6. In contrast, although IL-1β was significantly increased on day 5 in 
bleomycin-challenged C57BL/6 mice, expression peaked on day 21. Expression of  KC (31.64 ± 3.51 pg/
mL; P = 0.001), MCP-1 (565.4 ± 71.8 pg/mL; P = 0.018), IL-6 (89.06 ± 16.22 pg/mL; P = 0.128), and 
IL-1β (day 5: 14.71 ± 1.83 pg/mL; P = 0.0029; day 21: 18.26 ± 2.03 pg/mL; P = 0.0097) was attenuated in 
fpr1–/– mice compared with C57BL/6 mice (Figure 2, A–D).
To assess the role of  FPR-1 in the recruitment of  immune cells into the lung, we quantified the 
number of  neutrophils (NIMP+), T cells (CD3+), and inflammatory macrophages (CD68+) in tissue iso-
lated from challenged C57BL/6 and fpr1–/– mice. There was a significant attenuation in the recruitment 
of  neutrophils (4.686 ± 1.65 vs. 9.725 ± 1.44; P = 0.021) on day 1 and inflammatory macrophages on 
day 1 (11.17 ± 0.81 vs. 15.52 ± 1.16; P = 0.016) and day 5 (9.157 ± 1.85 vs. 17.42 ± 2.11; P = 0.022) in 
bleomycin-challenged fpr1–/– mice compared with C57BL/6 mice. In contrast, recruitment of  T cells on 
day 5 was comparable between fpr1–/– and C57BL/6 mice (P = 0.54) (Figure 2, E–G). Next, we assessed 
the phenotype of  tissue macrophages (F4/80+CD11b+) in C57BL/6 and fpr1–/– mice by quantifying the 
cell surface expression of  iNOS (M1 macrophage marker) and CD206 (M2 macrophage marker) by flow 
cytometry. There was little to no difference in the total number of  macrophages (P = 0.48) or the number 
of  iNOS+ M1 macrophages (P = 0.43) in challenged C57BL/6 mice compared with fpr1–/– mice. The 
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Figure 1. fpr1–/– mice are protected from bleomycin-induced lung fibrosis. (A) C57BL/6 and fpr1–/– mice were challenged intratracheally with saline (30 μl) 
or bleomycin sulfate (0.007 U in 30 μl saline) and lung tissue–harvested on days 1, 5, and 21. (B) Hydroxyproline (μg/lobe) content of lung tissue on days 5 
and 21. (C) Representative H&E-stained lung tissue on day 21. (D) Percentage area positive of Picrosirius red and (E) α-smooth muscle actin (αSMA) stain-
ing on day 21. Data represent the mean value of 20 randomly selected, nonoverlapping fields (original magnification, ×20). Relative gene expression of 
collagen type I (F), fibronectin (G), elastin (H), and MMP2 (I) in lung tissue on day 21 was assessed by qPCR. Gene expression was normalized to GAPDH as 
a loading control. n = 7–10 mice per group. No significant difference was seen between saline-treated C57BL/6 and fpr1–/– mice, and therefore saline-treat-
ed mice were pooled and presented as mean (red-hashed line). Data were analyzed using a Mann-Whitney U test and presented as box-and-whisker plots. 
*P < 0.05; **P < 0.01.
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number of  CD206+ M2 macrophages was significantly elevated on day 21 in challenged C57BL/6 mice 
compared with control mice. In contrast, the frequency of  CD206+ M2 macrophages in bleomycin-chal-
lenged fpr1–/– mice was not significantly different than control mice (P = 0.93) and was significantly less 
than in C57BL/6 mice (13.22 ± 2.38 vs. 34.16 ± 6.88; P = 0.019) (Figure 2, H–J).
To determine whether FPR-1 was directly regulating the fibrogenic response, we exposed C57BL/6 
and fpr1–/– mice to AdTGF-β1223/225 or adenovirus null vector control (4 × 108 PFUs) and harvested on day 
21 to assess fibrosis (Figure 3A). AdTGF-β1223/225 induced fibrosis to a similar degree in C57BL/6 and 
fpr1–/– mice, as indicated by an elevation in total lung collagen content (Figure 3C), an increase in the per-
centage area positive for Picrosirius red (Figure 3, B and E) and αSMA (Figure 3, B and D), and an increase 
in fibrogenic gene expression (Figure 3, F–J). These data suggest that FPR-1 is not directly involved in the 
fibrogenic response in the lung, but instead contributes to inflammation by driving immune cell recruitment 
and activation in response to tissue damage.
FPR-1 is not required for the initiation or progression of  fibrosis in the liver or kidney. To investigate whether FPR-1 
plays proinflammatory and/or profibrotic roles in the liver, we first utilized acute and chronic carbon tetrachlo-
ride-induced (CCl4-induced) models of liver injury and fibrosis. In the acute model, C57BL/6 and fpr1
–/– mice 
were given a single i.p. injection of CCl4 or olive oil (as a control) and were harvested after 24, 48, or 72 hours 
(Supplemental Figure 1A; supplemental material available online with this article; https://doi.org/10.1172/
Figure 2. fpr1–/– mice have reduced inflammation and M2 macrophages in response to challenge with bleomycin. Levels of KC (A), MCP1 (B), IL-1β (C), and IL-6 
(D) in lung tissue homogenates on days 5 and 21 after bleomycin challenge assessed by multiplex ELISA. Number of (E) NIMP+, (F) CD68+, and (G) CD3+ cells/
field in lung tissue on days 1 and 5 after bleomycin challenge. Data represent the mean value of n = 20 randomly selected, nonoverlapping (original magnifi-
cation, ×20) fields per mouse. Frequency of total macrophages (F4/80+ CD11b+) (H), M1 macrophages (F4/80+ CD11b+ iNOS+) (I), and M2 macrophages (F4/80+ 
CD11b+ CD206+) (J) in lung tissue were assessed by flow cytometry and presented as a percentage of live CD45+ cells. n = 7–12 mice per group for A and B. n = 4–7 
mice per group for H–J. No significant difference was seen between saline-treated C57BL/6 and fpr1–/– mice, and therefore saline-treated mice were pooled and 
presented as mean (red-hashed line). Data were analyzed using a Mann-Whitney U test and presented as box-and-whisker plots. *P < 0.05; **P < 0.01.
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CCl4 or olive oil for 8 weeks and were harvested 24 hours after the last dose of CCl4 (Figure 4A). The degree 
of liver injury as quantified by serum aspartate aminotransferase (AST) and alanine transaminase (ALT) levels 
was comparable in both C57BL/6 and fpr1–/– mice (Supplemental Figure 2, A and B). Similarly, and in contrast 
to the lung, recruitment of neutrophils (NIMP+) and inflammatory macrophages (CD68+) was comparably 
elevated in both C57BL/6 and fpr1–/– mice after acute (Supplemental Figure 1, D and E) or chronic (Figure 
4, G and H) CCl4 challenge. Moreover, proliferation, as quantified by the number of PCNA
+ hepatocytes 
(Supplemental Figure 1F and Supplemental Figure 2C) and inflammatory gene expression (Figure 4, I and 
J), was comparably elevated in both C57BL/6 and fpr1–/– mice. Activation of quiescent hepatic stellate cells 
Figure 3. fpr1–/– mice are not protected from adeno-TGF-β1–induced lung fibrosis. (A) C57BL/6 and fpr1–/– mice were 
challenged intratracheally with 4 × 108 PFUs of TGF-β1 adenovirus (Ad-TGF-β1223/225) or control virus (Ad-DL) in 30 μl 
sterile saline and lung tissue–harvested on day 21. (B) Representative α-smooth muscle actin–stained (αSMA-stained) 
and Picrosirius red–stained lung tissue on day 21. (C) Hydroxyproline (μg/lobe) content of lung tissue on days 5 and 21. 
(D) Percentage area positive of αSMA and (E) Picrosirius red staining on day 21. Data represent the mean value of 20 
randomly selected, nonoverlapping fields (original magnification, ×20). Relative gene expression of TGF-β1 (F), αSMA 
(G), Collagen 1a1 (H), Collagen 1a2 (I), and TIMP1 (J) in lung tissue on day 21 was assessed by qPCR. Gene expression was 
normalized to GAPDH as a loading control. n = 6–8 mice per group. No significant difference was seen between control 
virus–treated C57BL/6 and fpr1–/– mice, and therefore control virus mice were pooled and presented as mean (red-
hashed line). Data were analyzed using a Mann-Whitney U test and presented as box-and-whisker plots. All P > 0.05.
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in response to CCl4 is associated with the upregulation of α-SMA expression. Both C57BL/6 and fpr1
–/– mice 
had markedly increased numbers of αSMA+ myofibroblasts (Supplemental Figure 1G) 48 hours and 72 hours 
after CCl4 challenge, and this increase was maintained in chronic CCl4-challenged mice (Figure 4, B and C). 
Importantly, fibrosis, as measured histologically (Figure 4, B, D, and E) and biochemically (Figure 4F), was 
comparable between C57BL/6 and fpr1–/– mice, suggesting that FPR-1 is not required for initiation or progres-
sion of liver fibrosis in response to CCl4 challenge.
To conclusively evaluate the potential importance of FPR-1 in the liver, C57BL/6 and fpr1–/– mice were 
assessed in 2 further models of liver fibrosis driven by very different insults: the methionine/choline-deficient 
(MCD) diet model (Figure 5A) and the bile duct ligation (BDL) model (Figure 5G). Hepatic steatosis, as charac-
terized by the number of lipid droplets and total lipid area (Figure 5, B–D), and fibrosis, as characterized by an 
increase in the percentage area positive for Picrosirius red and αSMA (Figure 5, B, E, and F, and Supplemental 
Figure 3A) or fibrogenic gene expression (Supplemental Figure 3C), were comparable between C57BL/6 and 
fpr1–/– mice in the MCD diet model. Similarly, biliary expansion, as characterized by an increase in the percent-
age area positive for cytokeratin-19 (CK19), in response to similar levels of liver injury (Figure 5, H–J), and 
Figure 4. fpr1–/– mice are not protected from CCl4-induced liver fibrosis. (A) C57BL/6 and fpr1–/– mice were challenged 
biweekly for 8 weeks with i.p. injection of carbon tetrachloride (CCl4) at 2 μl/g body weight (CCl4/olive oil at 1:3 [vol/
vol]) or olive oil as a control. Mice were killed 24 hours after the last CCl4 injection. (B) Representative α-smooth muscle 
actin–stained (αSMA-stained) and Picrosirius red–stained liver tissue. Percentage area positive of (C) αSMA and (D) 
Picrosirius red staining. Data represent the mean value of n = 20 randomly selected, nonoverlapping fields (origi-
nal magnification, ×10). (E) Fibrosis score (0–4) according to the degree of collagen staining and scar formation. (F) 
Hydroxyproline (μg/g) content of liver tissue. Number of (G) NIMP+ and (H) CD68+ cells per field (original magnification, 
×20). Data represent the mean value of n = 20 randomly selected, nonoverlapping fields per mouse. Relative gene 
expression of KC (I) and MCP1 (J) in liver tissue was assessed by qPCR. Gene expression was normalized to GAPDH as 
a loading control. n = 5–9 mice per group. No significant difference was seen between olive oil–treated C57BL/6 and 
fpr1–/– mice, and therefore olive oil–treated mice were pooled and presented as mean (red-hashed line). Data were ana-
lyzed using a Mann-Whitney U test and presented as box-and-whisker plots. All P > 0.05. ALT, alanine transaminase; 
AST, aspartate aminotransferase.
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periportal fibrosis, as characterized above (Figure 5, H, K, and L, and Supplemental Figure 3, D and F), were 
comparable between C57BL/6 and fpr1–/– mice in the BDL model. Collectively, these data demonstrate that 
FPR-1 is not required for the development of hepatic fibrosis.
To determine the role of  FPR-1 in renal fibrosis, we utilized the unilateral ureteral obstruction (UUO) 
model of  kidney injury, whereby surgical ligation of  the ureter of  the left kidney triggers an increase in 
Figure 5. fpr1–/– mice are not protected from MCD- or BDL- induced liver fibrosis. (A) C57BL/6 and fpr1–/– mice were fed a methionine/choline-deficient 
(MCD) diet or control methionine/choline sufficient (MCS) diets and then harvested on week 6. (B) Representative H&E- and Picrosirius red–stained 
liver tissue. (C) The total number of lipid droplets and (D) total lipid area were quantified from H&E-stained liver sections. Percentage area positive of 
(E) α-smooth muscle actin (αSMA) and (F) Picrosirius red staining. Data represent the mean value of n = 20 randomly selected, nonoverlapping fields 
(original magnification, ×10). (G) C57BL/6 and fpr1–/– mice underwent bile duct ligation (BDL) and were harvested 10 days after surgery. (H) Representative 
cytokeratin-19– (CK19-) and Picrosirius red–stained liver tissue. (I) Serum alkaline phosphatase (ALK-P) levels expressed as units/liters (U/L) in BDL-injured 
mice. Percentage area positive of (J) CK19-, (K) αSMA-, and (L) Picrosirius red–stained liver sections. Data represent the mean value of n = 20 randomly 
selected, nonoverlapping fields (original magnification, ×10). n = 6–10 mice per group for A–F and n = 5–9 mice per group for G–L. Data were analyzed using 
a Mann-Whitney U test and presented as box-and-whisker plots. All P > 0.05. ALT, alanine transaminase; AST, aspartate aminotransferase; BDL, bile duct 
ligation; MCD, methionine/choline deficient; MCS, methionine/choline sufficient.
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hydrostatic pressure driving damage, inflammation, and ultimately fibrosis (Figure 6A). Immune cell recruit-
ment, as quantified by the number of  T cells (CD3+), neutrophils (NIMP+), and monocytes (CD68+) in 
tissue on day 5 and day 12 after UUO, was comparably elevated in both C57BL/6 and fpr1–/– mice (Figure 
6, B–D). Moreover, fibrosis, as quantified by percentage area positive for Picrosirius red (Figure 6, E and F), 
and myofibroblast activation, as quantified by percentage area positive for αSMA (Figure 6, G and H), were 
equally elevated in both C57BL/6 and fpr1–/– mice. Finally, interstitial expansion (Figure 6I) and tubular 
dilatation (Figure 6J) were quantified histologically and were not significantly different between C57BL/6 
and fpr1–/– mice. Taken together, these data suggest that FPR-1 is not required for initiation or progression of  
renal fibrosis in the UUO model.
Defective recruitment of  fpr1–/– neutrophils to the lung in response to injury. Neutrophil recruitment to the liver 
and kidney in response to CCl4 challenge or UUO-induced renal injury, respectively, was comparable between 
C57BL/6 and fpr1–/– mice. In contrast, neutrophil recruitment to the lungs of  fpr1–/– mice in response to bleo-
mycin-induced tissue injury was attenuated compared with C57BL/6 mice. Taken together, these data suggest 
that FPR-1 is required for effective homing of  neutrophils to the lung but not the liver or kidney. However, 
whether this is an intrinsic defect in the neutrophil or a defect in chemokine gradients in the lung of  fpr1–/– 
mice requires further investigation.
The inability of fpr1–/– neutrophils to activate in response to challenge with formyl peptides (fMIVIL, 
fMLFF, fMMYALF) was confirmed by a failure to upregulate CD11b expression compared with neutrophils 
isolated from C57BL/6 mice (Figure 7A). In contrast, neutrophils isolated from both fpr1–/– and C57BL/6 mice 
were activated by IL-18, IL-8, and GROα at comparable doses and to a comparable degree, ruling out het-
erologous desensitization of common chemotactic receptors on loss of FPR-1 (Figure 7B). Moreover, while 
phagocytosis of zymosan particles was comparable between neutrophils isolated from both fpr1–/– and C57BL/6 
mice, the production of superoxide in response to challenge with formyl peptides and the ability to migrate 
toward formyl peptides was attenuated in fpr1–/– neutrophils (Figure 7C). An air pouch model in C57BL/6 and 
fpr1–/– mice was used to further investigate neutrophil recruitment in vivo. Critically, the number of neutrophils 
recruited to the air pouch in response to IL-8 was comparable between C57BL/6 and fpr1–/– mice, whereas neu-
trophil recruitment was defective in fpr1–/– mice when responding to formyl peptides (Figure 7D). Comparable 
levels of activation (as measured by upregulation of CD11b and CD66b on GR1+ cells) of neutrophils recruited 
in response to IL-8 was observed between C57BL/6 and fpr1–/– mice; however, neutrophils were not recruited/
activated in response to formyl peptide (fMIVIL) in fpr1–/– mice (data not shown).
We next investigated neutrophil recruitment to the lungs of  C57BL/6 and fpr1–/– mice in response to 
challenge with LPS or IL-1β (both 1 μg/mL) to determine whether impaired neutrophil recruitment in 
fpr1–/– mice was specific to lung injury induced by bleomycin or was seen in response to other inflammatory 
challenges. Critically, neutrophil numbers in the lungs were comparably elevated 1 day after LPS or IL-1β 
challenge in C57BL/6 and fpr1–/– mice (Figure 7E), thus confirming that FPR-1–deficient neutrophils are 
effectively recruited in response to non-FPR-1 ligands. Taken together, these data show that fpr1–/– neutro-
phils can be activated by and recruited toward a number of  chemokines commonly elevated in damaged 
and fibrotic lung tissue, being exclusively defective in their ability to respond to FPR-1 ligands.
Next, we performed an adoptive transfer experiment in C57BL/6 and fpr1–/– mice to determine whether 
fpr1–/– neutrophils could be effectively recruited to the lungs of  injured C57BL/6 mice. To do this, we iso-
lated neutrophils from C57BL/6 and fpr1–/– donor mice and labeled them ex vivo with CFSE (C57BL/6) or 
Violet (fpr1–/–). Labeled cells were mixed 1:1 and injected intravenously (1.5 × 106 cells) into bleomycin-in-
jured recipient mice (C57BL/6 and fpr1–/–). After 2 hours, mice were culled and lung and liver homogenates 
were analyzed by flow cytometry to quantify neutrophil migration. CFSE-labeled C57BL/6 neutrophils 
were effectively recruited to the injured lung in both C57BL/6 and fpr1–/– mice, suggesting that the chemo-
kine gradients in the lungs of  fpr1–/– mice can effectively recruit neutrophils. In contrast, the number of  
Violet-labeled fpr1–/– neutrophils recruited was significantly attenuated in both C57BL/6 and fpr1–/– mice, 
suggesting that the defect lies with the fpr1–/– neutrophils rather than the lung microenvironment (Figure 7, 
F and G). Little to no nonspecific recruitment of  labeled neutrophils was observed to the uninjured liver 
(Figure 7G). These data suggest that FPR-1 expression on neutrophils is required for their effective homing 
to the lung after injury, and by extension, FPR-1 ligands are the primary neutrophil recruitment signal pro-
duced by the bleomycin-challenged lung.
Neutrophil depletion reduces bleomycin-induced lung inflammation and fibrosis. We next determined whether neu-
trophils are required for lung inflammation and fibrosis by carrying out a neutrophil depletion experiment. 
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To deplete neutrophils, we surgically implanted minipumps containing either a Ly6G 1A8–depleting antibody 
(20) or an IgG isotype control antibody 2 days before bleomycin challenge. We assessed the efficacy of neutro-
phil depletion on day 1 and quantified inflammation and fibrosis on day 21 (Figure 8A). On day 1, the total 
number of cells in the bronchoalveolar lavage (BAL) was not significantly different between bleomycin-chal-
lenged IgG- and Ly6G-treated mice, with both elevated above saline-challenged mice (Figure 8B). However, 
neutrophils as a percentage of BAL cells (Figure 8C) and the number of neutrophils (NIMP+) in lung tissue, 
as assessed by IHC, were significantly reduced in Ly6G-treated mice (Figure 8D). Critically, fibrosis, as quan-
tified by Picrosirius red (Figure 8, E and F) and αSMA (Figure 8, E and G), was significantly attenuated in 
Ly6G-treated mice compared with IgG-treated mice, with levels of both comparable to saline-challenged mice. 
Similarly, the number of inflammatory macrophages (CD68+) in lung tissue was attenuated in Ly6G-treated 
mice but the number of T cells (CD3+) was not affected (Figure 8, H and I). These data suggest that neutrophils 
are required for efficient recruitment of inflammatory macrophages to the damaged lung and for the devel-
opment of fibrosis. Moreover, FPR-1 and its ligands are critical for regulating neutrophil recruitment, and, as 
Figure 6. fpr1–/– mice are not protected from 
fibrosis in the unilateral ureteral obstruction 
model of kidney injury. (A) The left kidney 
of C57BL/6 and fpr1–/– mice was obstructed 
by ligation of the corresponding ureter. The 
right kidney underwent the same surgical 
procedure without ligation. Mice were killed on 
days 5 and 12 after surgery and kidney tissue 
harvested. Number of (B) CD3+, (C) NIMP+, and 
(D) CD68+ cells per field (original magnification, 
×20). Data represent the mean value of n = 
20 randomly selected, nonoverlapping fields 
per mouse. Representative (E) Picrosirius red–
stained and (G) α-smooth muscle actin–stained 
(αSMA-stained) kidney tissue. Percentage area 
positive of (F) Picrosirius red and (H) αSMA 
staining. Data represent the mean value of n 
= 20 randomly selected, nonoverlapping fields 
(original magnification, ×10). (I) Interstitial 
expansion and (J) tubular dilation as a percent-
age of grid intersections (excluding glomeruli) 
overlaying interstitial areas and tubular lumine. 
Data represent the mean value of n = 20 ran-
domly selected, nonoverlapping fields (original 
magnification, ×20). n = 6–7 mice per group. No 
significant difference was seen between the 
right kidneys of C57BL/6 and fpr1–/– mice, and 
therefore mice were pooled and presented as 
mean (red-hashed line). Data were analyzed 
using a Mann-Whitney U test and presented as 
box-and-whisker plots. P > 0.05.
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Figure 7. FPR-1 is required for effective neutrophil migration to injured lung tissue. Bone marrow derived cells from C57BL/6 and fpr1–/– mice were 
stimulated with formyl peptides (fMIVIL, fMLFF, fMMYALF) (A) or IL-18, IL-8, and GROα (B) and the change in CD11b expression on neutrophils (GR1+ cells) 
assessed by flow cytometry. (C) Bone marrow–derived neutrophils (>95% purity) from C57BL/6 and fpr1–/– mice were assessed for their ability to release 
superoxide, phagocytose zymosan particles and migrate toward formyl peptides. (D) C57BL/6 and fpr1–/– mice were stimulated intrapouch for 4 hours 
with IL-8 (250 μM) or fMIVIL (3 μM) and total cell recruitment measured in an inflammatory subcutaneous air pouch model by flow cytometry. Dotted 
line indicates mean total cell influx observed for control group with carboxymethyl cellulose carrier alone. (E) C57BL/6 and fpr1–/– mice were challenged 
intratracheally with saline (30 μl), LPS (1 μg/mL), or IL-1β (1 μg/mL) and lung tissue harvested on day 1. Data represent the mean number of Ly6G+ cells 
of n = 20 randomly selected, nonoverlapping fields (original magnification, ×20) per mouse. Dotted line indicates mean number of Ly6G+ cells observed 
for saline-challenged mice. Bone marrow–derived neutrophils (>95% purity) were isolated from C57BL/6 and fpr1–/– mice, labeled (CFSE, C57BL/6; Violet, 
fpr1–/–), mixed (1:1 ratio), and injected via a single intravenous injection into recipient (C57BL/6 and fpr1–/–) mice. After transfer of cells, mice were chal-
lenged with bleomycin to induce acute pulmonary injury and culled after 2 hours. Lung (G, top) and liver homogenates (G, bottom) were analyzed by flow 
cytometry to quantify neutrophil migration (F and G). n = 6–7 mice per group for A–E and n = 8 mice per group for F and G. Data were analyzed using a 
Mann-Whitney U test and presented as box-and-whisker plots. *P < 0.05; **P < 0.01.
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such, they are likely to be critical molecular initiators of the cellular events that lead to fibrosis and should be 
considered further as novel antifibrotic therapies in the lung.
Discussion
Fibrosis is the dysregulated accumulation of  collagen and ECM constituents and can affect any tissue or 
organ (3). The mechanisms underlying fibrosis can be either core, involved in the initiation or progression 
of  fibrosis in multiple organs, or organ specific. In this study, we describe a tissue-specific role for FPR-1 in 
Figure 8. Neutrophil depletion attenuates bleomycin-induced lung fibrosis. (A) Osmotic minipumps loaded with anti-Ly6G or IgG2a control antibodies 
were implanted subcutaneously into C57BL/6 mice. After 48 hours the mice were challenged intratracheally with saline (30 μl) or bleomycin sulfate (0.007 
U in 30 μl saline) and bronchoalveolar lavage (BAL) and lung tissue–harvested on days 1 and 21. Total cell numbers (B) and percentage of neutrophils, 
eosinophils, lymphocytes, and monocytes/macrophages (C) in BAL on day 1 were assessed by cytospin differential cell counts. (D) Number of NIMP+ cells 
per field (original magnification, ×20) on day 1. Data represent the mean value of n = 20 randomly selected, nonoverlapping fields per mouse. (E) Repre-
sentative Picrosirius red– and α-smooth muscle actin–stained (αSMA-stained) lung tissue on day 21. Percentage area positive for (F) Picrosirius red and 
(G) αSMA staining on day 21. Data represent the mean value of n = 20 randomly selected, nonoverlapping fields (original magnification, ×10). Number of 
(H) CD68+ and (I) CD3+ cells per field (original magnification, ×20) on day 21. Data represent the mean value of n = 20 randomly selected, nonoverlapping 
fields per mouse. No significant difference was seen between saline-treated C57BL/6 and fpr1–/– mice, and therefore saline-treated mice were pooled and 
presented as mean (red-hashed line). n = 5 mice per group for A–D and n = 8–9 mice per group for E–I. Data were analyzed using a Mann-Whitney U test 
and presented as box-and-whisker plots. *P < 0.05; **P < 0.01. IT, intratracheal.
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the development of  pulmonary fibrosis, with FPR-1 being entirely dispensable in the development of  hepat-
ic and renal fibrosis. Mechanistically, we show that FPR-1 is required for effective homing of  neutrophils to 
damaged lung tissue and that depletion of  neutrophils protects mice from bleomycin-induced pulmonary 
fibrosis. A limitation of  this study is that conclusions have been drawn exclusively from murine models of  
fibrosis, predominantly the bleomycin-induced lung fibrosis model. Although this model of  lung fibrosis 
can be criticized (it is performed in young animals [8–10 weeks], with rapid onset of  disease [21 days] and 
is induced by a nonphysiologically relevant stimulus), it is still regarded as the reluctant gold standard for 
the field and provides the foundation for the majority of  preclinical studies performed (21–23). Another 
criticism of  the model is whether bleomycin-induced acute lung injury resolves in those animals that sur-
vive. Recently, Limjunyawong et al. followed mice for 6 months after a single bleomycin challenge and 
found that while there is some repair, the injury never fully resolves, with persistent fibrosis that may have 
similarities to many features of  human idiopathic pulmonary fibrosis (IPF) (24).
Neutrophils are the most abundant inflammatory cells at the earliest stages of  wound healing but are 
subsequently replaced by infiltrating inflammatory macrophages after neutrophil degranulation. We observed 
that depletion of  neutrophils prevents inflammatory macrophage recruitment to the damaged lung, indicating 
an important initiator role for neutrophils in lung inflammation that is required for subsequent inflammatory 
macrophage-driven events. Of note, it was recently reported in a model of  sterile liver injury that recruited 
neutrophils eventually leave the organ by a highly regulated process and that this migration back into the 
peripheral circulation is a requirement for subsequent monocyte recruitment (25). Our data therefore sup-
port emerging evidence that neutrophils are important regulators of  inflammatory macrophage infiltration to 
damaged tissues. Despite their relatively short temporal presence, neutrophils play a critical role in preventing 
infection through the generation of  antimicrobial peptides, reactive oxygen species, and proteases. However 
these mediators may also damage the host and can have long-lasting effects on the speed and quality of  tissue 
repair (26). Recently, there have been a number of  reports that suggest neutrophils play an important role in 
the initiation and progression of  pulmonary fibrosis. For example the depletion of  neutrophils using anti-
GR1 or anti-Ly6G antibodies significantly decreased pulmonary inflammation and fibrosis in murine models 
of  hypersensitivity pneumonitis (27) and Paracoccidioides brasiliensis–induced pulmonary fibrosis (28). Mice 
deficient in P2Y2 fail to recruit neutrophil and have attenuated fibrosis in response to bleomycin challenge 
and treatment of  mice with a CXCR2 antagonist reduced airway neutrophil transmigration and pulmonary 
fibrosis (29, 30). Moreover, a number of  studies have demonstrated a critical role for neutrophil elastase in 
pulmonary fibrosis. Neutrophil elastase–null mice are protected from bleomycin-induced pulmonary fibrosis 
(31) and a similar protective effect is seen in mice treated with the neutrophil elastase inhibitor sivelestat 
(32). Critically, the number of  neutrophils and levels of  the neutrophil chemoattractant IL-8 are increased 
in patients with IPF compared with healthy subjects (33), and neutrophilia has been shown to predict early 
mortality in patients with IPF (34). Taken together, these data imply a critical role for neutrophils and their 
secreted products in the initiation and progression of  fibrosis in the lung. Here, we provide strong experi-
mental evidence that FPR-1 is essential for participation of  neutrophils in lung fibrosis and suggest that the 
receptor and/or its ligands are rational therapeutic targets.
In contrast, the role of  neutrophils in hepatic and renal fibrosis is less clear, with some studies 
reporting little to no involvement and others showing a critical role for neutrophils (35–38). Recently, 
it has been reported that infusion of  neutrophils into mice with established CCl4-induced liver fibrosis 
significantly reduced collagen accumulation, suggesting that neutrophils can effectively reduce fibrosis. 
The same study also demonstrated that depletion of  neutrophils significantly delayed resolution of  liver 
fibrosis, indicating that neutrophils are involved in natural fibrosis resolution in the liver (39). Overall, 
these data and our own support the idea that neutrophils play a pathological role in the development and 
progression of  pulmonary fibrosis but add little to the uncertainty regarding the role of  neutrophils in the 
development of  hepatic and renal fibrosis.
An important role for formyl peptides and FPR-1 in the lung has previously been described (40–42). 
Acute respiratory distress syndrome (ARDS) is a neutrophil-dominant lung disease and formyl peptides are 
found at elevated levels in BAL fluid and serum from patients with ARDS. Intratracheal installation of  hydro-
chloric acid (pH 2.0) acts as a model of  sterile lung injury in mice and demonstrated a critical role for FPR-1 
in recruitment of  neutrophils and inflammation (40). Studies have also demonstrated that neutrophils are 
increased in chronic obstructive pulmonary disease (COPD) lungs and that neutrophil-associated products 
correlate with the development and severity of  COPD (41). The peptide fMLF is an active component of  
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cigarette smoke, a primary risk factor for the development of  COPD. Compared with WT mice, fpr1–/– mice 
displayed a decrease in the migration of  neutrophils to the lung after exposure to cigarette smoke (42).
The ability of  bacterial and mitochondrial formyl peptides to act as neutrophil chemoattractants is 
well established; however, neutrophils are also uniquely sensitive to a vast array of  other chemoattractants, 
including complement fragments, lipid mediators, and a multitude of  chemokines (43). Our data strongly 
argue that recruitment of  neutrophils to the lungs of  injured mice occurs primarily through ligands that sig-
nal via FPR-1, as non-FPR-1 ligands (IL-1β and LPS) effectively recruited fpr1–/– neutrophils to the lungs. 
However, whether FPR-1–mediated recruitment is via binding of  FPR-1 to mitochondrial formyl peptides 
(8, 9) or one of  the other recently identified alternative ligands (10–12) is not clear. Moreover, the human 
FPR family has 3 members, namely, FPR-1, FPR-2, FPR-3, whereas the mouse FPR family is more com-
plex and contains at least 8 related genes, 3 of  which are expressed on immune cells and have similarities 
to human FPR-1, FPR-2, and FPR-3 (14, 44–46). The failure to recruit fpr1–/– neutrophils to the lung in 
response to injury indicates that the other members of  the FPR family are unable to compensate for the 
loss of  FPR-1. In contrast, fpr1–/– neutrophils are effectively recruited to the liver and kidney in response 
to injury, suggesting that other receptors or potentially other members of  the FPR family are the primary 
drivers of  neutrophil recruitment in these organs.
In summary, we have shown that FPR-1 expression on neutrophils is required for effective homing of  
neutrophils to the damaged lung. Moreover, we show that fpr1–/– mice and neutrophil-depleted C57BL/6 
WT mice are protected from bleomycin-induced pulmonary fibrosis, highlighting the potential therapeutic 
benefit of  targeting FPR-1 or neutrophils in the fibrotic lung.
Methods
Lung inflammation and fibrosis. C57BL/6 and fpr1–/– mice (male and female, 8–10 weeks old) were anesthe-
tized with an i.p. injection of  ketamine (80 mg/kg)/xylazine (8 mg/kg) before intratracheal challenge with 
a single dose of  saline (30 μl), bleomycin sulfate (0.007 U in 30 μl saline), IL-1β (1 μg/mL in 30 μl saline), 
or LPS ([MilliporeSigma] 1 μg/mL in 30 μl saline). Mice were killed by sodium pentobarbital overdose 1, 
5, or 21 days after challenge. BAL was performed by cannulating the trachea with an Insyte venous catheter 
(BD Bioscience) and administering ice-cooled PBS (1 mL) supplemented with EDTA (5 mM). Cells were 
isolated for total (EVE cell counter [NanoEntek]) and differential cell counts (Wrights-Giemsa) with the 
supernatant stored for analysis. Matching lung lobes were harvested for RNA isolation, protein isolation, 
histology, and hydroxyproline assay.
TGF-β1 adenovirus-induced lung fibrosis. To induce lung fibrosis, C57BL/6 and fpr1–/– mice (male, 8–10 
weeks old) were anesthetized before intratracheal instillation of  4 × 108 PFUs of  TGF-β1 adenovirus 
(Ad-TGF-β1223/225) or control virus (Ad-DL) in 30 μl sterile saline (47). This virus expresses active TGF-β1 
in the lung and produces extensive and progressive fibrosis. Mice were killed by sodium pentobarbital over-
dose 21 days after instillation and matching lung lobes were harvested for RNA isolation, protein isolation, 
histology, and hydroxyproline assay.
CCl4-induced liver injury and fibrosis. To induce acute liver injury, C57BL/6 and fpr1
–/– mice (male, 8–10 
weeks old) were challenged with a single i.p. dose of  CCl4 at 2 μl/g body weight (CCl4/olive oil at 1:1 [vol/
vol]). Mice were humanely killed 24, 48, and 72 hours after challenge. To induce liver fibrosis, C57BL/6 
and fpr1–/– mice (male, 8–10 weeks old) were challenged biweekly for 8 weeks with i.p. injection of  CCl4 at 
2 μl/g body weight (CCl4/olive oil at 1:3 [vol/vol]). Mice were killed 24 hours after the last CCl4 injection. 
For both models, several tissue samples from throughout the large lobe were pooled for RNA and protein 
isolation. Tissue samples from the median, right, and left large lobes were sampled for histology. ALT and 
AST levels in serum were measured by NHS Biochemistry, Royal Victoria Infirmary, Newcastle upon Tyne 
using a standard protocol.
BDL model. All surgical procedures were carried out according to aseptic protocol approved by the 
Comparative Biology Centre, Newcastle University and Animal Scientific guidelines implemented by 
the United Kingdom Home Office. To induce cholestatic liver disease and periportal fibrosis, C57BL/6 
and fpr1–/– mice (male, 12–14 weeks old) underwent BDL. Briefly, mice were anesthetized with iso-
flurane; the bile duct was then exposed by ventral laparotomy and double ligated using 5-0 nylon 
sterile suture wire. The incision site was sealed by suturing and glue. Sham mice underwent the same 
procedure without ligation of  the bile duct. Mice were killed 10 days after surgery and tissues were 
harvested for further analysis.
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MCD diet model. To induce fibrosis on the background of  hepatic steatosis and inflammation, C57BL/6 
and fpr1–/– mice (male, 8–10 weeks old) were fed a MCD diet. Control mice received a methionine/choline 
sufficient diet. Mice were killed on week 6 and tissues were harvested for further analysis. Alkaline phos-
phatase (ALK-P) levels in serum were measured by NHS Biochemistry, Royal Victoria Infirmary, Newcas-
tle upon Tyne, using a standard protocol.
UUO-induced kidney fibrosis. To induce kidney fibrosis, C57BL/6 and fpr1–/– mice (female, 6–7 weeks 
old) underwent UUO. Mice were anesthetized by isoflurane plus oxygen; the left ureter was then exposed 
via a ventral laparotomy and the left kidney obstructed by ligation of  the corresponding ureter with 5-0 
nylon sterile suture wire. The incision site was sealed by suturing and using glue. The contralateral kidney 
underwent the same surgical procedure without ligation and was used as a sham surgery control. Mice 
were killed 5 and 12 days after surgery. Tissue from the experimental (left) and control (right) kidneys were 
sampled for histology.
Ly6G-mediated neutrophil depletion. C57BL/6 and fpr1–/– mice (male, 8–10 weeks old) were anesthetized 
by isoflurane plus oxygen. ALZET osmotic minipumps loaded with either anti-Ly6G (2A3) or IgG2a con-
trol (1A8) antibodies (BioXcell) were implanted subcutaneously to allow systemic and continuous deliv-
ery of  the antibodies. ALZET 4-week pumps (model 2004) with a release rate of  0.25 μl/hour (28.5 μg/
mouse/d) were used for the 21-day time point. ALZET 7-day pumps (model 1007D) with a release rate of  
0.5 μl/hour (57 μg/mouse/d) were used for the 1-day time point. Mice were challenged with a single dose 
of  saline (30 μl) or bleomycin sulfate (0.007 U in 30 μl saline) 48 hours after implant of  the minipumps, 
killed by sodium pentobarbital overdose on day 1 or 21, and harvested as described above.
Air pouch inflammation model. An air pouch was induced on the back of  C57BL/6 and fpr1–/– mice 
(female, 6–8 weeks old) by subcutaneously injecting 2.5 mL of  sterile filtered air under light isoflurane 
anesthesia, allowing recovery and then reinflating in the same location 72 hours later. After another 72 
hours, mice were injected intrapouch with human recombinant IL-8 (250 μM) or fMIVIL (3 μM) (chosen 
due to its higher potency in mice) in a carboxymethyl cellulose (CMC) carrier (0.75% CMC, 0.1% DMSO 
in 0.5 mL PBS) to retain the protein/peptide in the pouch. CMC carrier injected intrapouch was used as a 
control. Mice were killed by sodium pentobarbital overdose 4 hours after challenge and the pouch lavaged 
with 1 mL ice-cold heparinized PBS (5 U/mL). Total cell counts and activation markers (MFI or percent 
of  positive cells for CD11b or CD66a expression) on GR1+ neutrophils were assessed using flow cytometry 
and normalized for volume of  lavage recovered.
Primary mouse bone marrow neutrophil isolation. Bone marrow–derived neutrophils were prepared by centrif-
ugation of  a single Percoll layer gradient as previously described (48). Neutrophils from C57BL/6 and fpr1–/– 
mice were evaluated in terms of  their chemotactic ability, release of  superoxide anions, and phagocytosis.
Neutrophil chemotaxis. Freshly isolated mouse bone marrow derived neutrophils (2.5 × 107 cells/mL) in 
1% autologous serum were added to the central wells in an agarose (2%)/gelatin (2%)/BSA (2.5%)/medi-
um slide. Media containing fMLF (100 nm) or medium alone were added in duplicate to each slide and the 
slide incubated at 37°C/5% CO2 for 2 hours before fixation in 2.5% paraformaldehyde. Slides were stained 
with Giemsa solution (MilliporeSigma) and migrated cells quantified.
ROS production. To measure superoxide anion release, freshly isolated mouse neutrophils (1 × 107 cells/
mL) were resuspended in HBSS with a priming agonist (PAF 100 nm) for 10 minutes at 37°C. Subsequent 
stimulation with superoxide dismutase (SOD, Sigma-Aldrich, 200 U), cytochrome c (1 mg/mL; Sigma-Al-
drich), and fMLF/HBSS (100 nm, Sigma-Aldrich) was performed for 15 minutes in a shaking water bath 
at 37°C. The reaction was stopped by placing the cells on ice. Supernatants were subsequently analyzed in 
96-well plate at 550 nm using a plate reader with the generation of  O2
– determined by the amount of  super-
oxide dismutase–inhibitable reduction of  cytochrome c. Results are expressed as nanomoles of  superoxide 
anions generated per 106 neutrophils, calculated using the extinction coefficient 21 × 103 M–1cm–1.
Phagocytosis. Freshly isolated mouse neutrophils (1 × 106/mL) were plated on a 24-well plate for 1 hour 
to allow cell adherence. Opsonized zymosan was added to each well and incubated for 1 hour, at which 
point excess zymosan was washed off. Cells were fixed with methanol and stained with Giemsa solution 
(MilliporeSigma). Phagocytosis was quantified by counting neutrophils with 2 or more engulfed zymosan 
particles in four randomly selected fields with a minimum 100 neutrophils per field.
Adoptive transfer and neutrophil tracking. Donor mice (C57BL/6 and fpr1–/–) were culled and bone mar-
row–derived neutrophils isolated. To enable tracking via flow cytometry, cells were fluorescently labeled 
with CFSE (C57BL/6) or Violet (fpr1–/–) mixed in a 1:1 ratio and injected via a single intravenous injection 
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(1.5 × 106 cells) into recipient mice (C57BL/6 and fpr1–/–). Recipient mice were intratracheally challenged 
with bleomycin sulfate (0.007 U in 30 μl saline) 24 hours before injection of  cells to induce acute pulmo-
nary injury and trigger neutrophil homing to the affected area. After 2 hours, mice were culled and lung/
liver homogenates were analyzed by flow cytometry to track neutrophil migration.
Fibrosis scoring of  Picrosirius red–stained liver tissue. Paraffin-embedded formalin-fixed sections (5-μm 
thick) were stained with 0.1% Sirius red F3B following a standard protocol. Fibrosis was scored (0–4) 
according to the degree of  collagen staining and scar formation as follows; 0, no fibrosis; 1, mild; 2, mod-
erate; 3, severe (>2 vessels linked and multilayered deposition); and 4, cirrhosis (multiple instances of  
bridging fibrosis and nodule formation).
Scoring of  interstitial expansion and tubular dilation in kidney tissue. Paraffin-embedded formalin-fixed sec-
tions (5-μm thick) were stained with periodic acid–Schiff  (PAS) following a standard protocol. Interstitial 
expansion and tubular dilation in the experimental and contralateral kidneys were calculated as a percent-
age of  grid intersections (excluding glomeruli) overlaying interstitial areas and tubular lumine. A total of  20 
randomly selected, nonoverlapping fields in the cortical region were scored (original magnification, ×20).
Hydroxyproline assay. For assessment of  fibrosis, matched lung lobes were weighed and digested with 2 
mL of  6N HCl to measure the quantity of  hydroxyproline as previously described (49).
IHC. IHC was performed on paraffin-embedded formalin-fixed tissue sections (5-μm thick). Briefly, 
deparaffinized sections were incubated in hydrogen peroxide/methanol followed by either proteinase K (20 
μg/mL) or citrate antigen retrieval. Endogenous avidin and biotin were blocked using the Vector Avidin/
Biotin Blocking Kit (Vector Laboratories), and further blocking was achieved using 20% swine serum. 
Sections were incubated overnight with primary antibodies (αSMA [1A4, Sigma-Aldrich], NIMP [R-14, 
Abcam], Ly6G [1A8, BioXcell], CD68 [OABB00472, Aviva Biosystems], CD3 [CD3-12, Bio-Rad], PCNA 
[PC10, Abcam], and CK19 [ab84632, Abcam]). On the next day, sections were washed and incubated with 
biotinylated secondary antibodies, followed by VECTASTAIN Elite ABC Reagent (Vector Laboratories). 
Antigens were visualized using diaminobenzidine peroxidase or ALK-P and counterstained with Mayer’s 
hematoxylin. The number of  positive cells per field was calculated by taking the mean of  20 random-
ly selected, nonoverlapping fields (original magnification, ×20). To calculate percentage area positive, a 
threshold for positive staining was defined and applied to 20 randomly selected, nonoverlapping fields 
(original magnification, ×10) using Nikon Elements Software.
RNA isolation and real-time PCR. Total RNA was isolated using the RNeasy Kit (QIAGEN) and RNA 
concentration was quantified by Nanodrop. Complementary DNA synthesis was performed using a 
Promega kit (Promega) and real-time PCR was performed with SYBR Green JumpStart Taq ready mix 
following the manufacturer’s instructions and normalized to GAPDH. Primer sequences used are reported 
in Supplemental Table 1.
Multiplex electrochemiluminescence assay. IL-1β, MCP1, KC, and IL-6 concentrations in lung homoge-
nates were measured using Meso Scale Discovery electrochemiluminescence detection kits according to 
the manufacturer’s instructions.
Flow cytometry analysis. Lung leukocytes were isolated by digesting matched lung lobes in DNase 
(MilliporeSigma) (25 μg/mL) and Liberase (MilliporeSigma) (18 μg/mL) for 60 minutes with rocking at 
37°C, crushing through 70-μm cell strainers, and centrifuging at 350 g for 10 minutes. Erythrocytes were 
eliminated using ACK Lysing Buffer (Gibco). Lung leukocyte numbers were determined by flow rate. To 
assess cell populations and macrophage phenotype, lung leukocytes (4 × 105) were labeled with a viabil-
ity dye (Invitrogen Live/Dead Aqua), preincubated with unlabeled anti-CD16/32 antibody, and stained 
with: CD45-APC-Cy7 (30-F11, BioLegend), CD11b-Percp (M1/70, BioLegend), F4/80-BV421 (BM8, 
BioLegend), CD206-APC (C068C2, BioLegend), and iNOS (K13-A, Biorbyt). Macrophages were gated 
as CD45+F4/80+/CD11b+ and then separated into distinct M1 (CD45+F4/80+/CD11b+/iNOS+) and M2 
(CD45+F4/80+/CD11b+/CD206+) subsets. Flow cytometry was performed using a FACSCanto II and 
data were analyzed using FlowJo (Tree Star).
Bone marrow GR1+ cell activation. The method for isolating bone marrow cells from mice was derived 
from Southgate et al. (50). Briefly, bone marrow cells were isolated from the femurs of  n = 3 C57BL/6 
or fpr1–/– mice, pooled, and passed through a 40-μm cell strainer. Cells were resuspended in RPMI 1640 
Glutamax with 2% bovine serum albumin and seeded into a 96-well, round-bottom plate at 8 × 104 cells/
well in a final volume of  200 μl. Cells were stimulated with a titration of  human recombinant IL-8, murine 
recombinant IL-18, human recombinant GROα, or various formyl peptides (R&D Systems, MBL, R&D 
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Systems and custom synthesized by CRB or Bachem, respectively). Plates were incubated at 37oC, 5% CO2 
for 50 minutes and stained with anti–GR1-APC and anti–CD11b-PE to allow quantification of  CD11b 
expression on live GR1+ve cells.
Statistics. Data were analyzed using Mann-Whitney U test. Significance was defined by a P value less 
than 0.05. Results are presented as box-and-whisker plots or individual values as appropriate.
Study approval. All animal experiments were conducted in accordance with the United Kingdom Ani-
mals Scientific Procedures Act of  1986, and under approval from the Newcastle Ethical Review Committee 
and a United Kingdom Home Office license. C57BL/6 mice were obtained from an in-house breeding 
colony (Comparative Biology Centre). fpr1–/– mice were originally obtained from MedImmune and subse-
quently maintained on a C57BL/6 background at Newcastle University.
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